CAS 1802525-61-6
:LRRK2 inhibitor 1
Description:
LRRK2 inhibitor 1, identified by its CAS number 1802525-61-6, is a small molecule that selectively inhibits the activity of the leucine-rich repeat kinase 2 (LRRK2) enzyme. This enzyme is implicated in various neurodegenerative diseases, particularly Parkinson's disease, making its inhibition a target for therapeutic intervention. The compound is characterized by its ability to modulate kinase activity, potentially leading to neuroprotective effects. It typically exhibits a specific binding affinity to the LRRK2 protein, which is crucial for its function as an inhibitor. The chemical structure of LRRK2 inhibitor 1 includes functional groups that enhance its potency and selectivity, contributing to its pharmacological profile. Additionally, studies have shown that it can influence downstream signaling pathways associated with neuronal health. As with many experimental compounds, further research is necessary to fully understand its efficacy, safety, and potential side effects in clinical applications.
Formula:C20H23N5O4
Synonyms:- Methanone, [4-[(4-ethoxy-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino]-3-methoxyphenyl]-4-morpholinyl-
- (4-((4-ethoxy-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)phenyl)(morpholino)methanone
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
LRRK2 inhibitor 1
CAS:<p>LRRK2 inhibitor 1 is a selective and potent LRRK2 inhibitor with an IC50 of 13 nM.LRRK2 inhibitor 1 inhibits DCLK1 kinase with an IC50 value of 2.61 nM.</p>Formula:C20H23N5O4Purity:99.94%Color and Shape:SolidMolecular weight:397.43
